Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Innate pattern recognition receptors (PRRs) sensing influenza RNA are a group of immune sensors that detect viral genetic material to initiate an antiviral response. The primary sensors include Retinoic acid-inducible gene I (RIG-I), which detects 5-triphosphorylated or diphosphorylated short double-stranded RNA in the cytoplasm (Hornung et al., 2006, Science), and Toll-like receptors 7 and 8 (TLR7/8), which recognize single-stranded RNA within endosomes (Diebold et al., 2004, Science). Upon activation, these receptors trigger signaling cascades involving adapter proteins like MAVS or MyD88, leading to the production of Type I interferons and pro-inflammatory cytokines (Kawai & Akira, 2010, Nature Immunology). While essential for clearing the influenza virus, overactivation of these pathways can lead to a "cytokine storm" and severe lung pathology (Teijaro et al., 2011, Science). Therapeutic strategies involve using agonists as vaccine adjuvants or antivirals, and antagonists to mitigate hyper-inflammation during severe infection (Pang & Iwasaki, 2011, Mucosal Immunology). Drugs like Imiquimod and Resiquimod target these pathways to enhance immune detection, while others are in development to modulate the intensity of the response.
Agonism of these receptors stimulates the innate immune system by mimicking viral RNA, leading to the induction of interferons and cytokines that restrict viral replication and enhance vaccine efficacy.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pattern recognition receptors sensing influenza RNA (RNA-sensing PRRs).